First Single-blind Sequential Placebo-controlled Prospective Phase IIA Pilot Study Assessing the Effects of PXT00864 in Mild AD Patients
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Acamprosate/baclofen (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms PLEODIAL-I
- Sponsors Pharnext
- 20 Jul 2017 Results from PLEODIAL clinical trial (this study and NCT02361242), presented at the Alzheimer's Association International Conference 2017.
- 13 Dec 2016 Results published in the Pharnext Media Release.
- 13 Dec 2016 According to a Pharnext media release, data from PLEODIAL clinical trial (this study and CTP 253932) presented at the 9th Clinical Trials on Alzheime's Disease (CTAD) conference.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History